Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Prix Galien

- PMLiVE

Orphan drugs dominate UK Prix Galien shortlist, medtech debuts

Seven treatments for rare conditions have been selected for the final

- PMLiVE

Chiesi’s Holoclar wins UK Prix Galien orphan drug award

Novartis and Astellas also scoop prizes at the prestigious ceremony

- PMLiVE

AZ, BMS and Boehringer among UK Prix Galien finalists

They join Alexion, Chiesi, Janssen, Novartis, Otsuka and Takeda

- PMLiVE

Pharma could make more of its real world evidence

As the ‘cost versus value’ argument rears its head once again a new award could help pharma reaffirm the value of its medicines

- PMLiVE

UK Prix Galien opens for entries

Pharma R&D accolades will include a new real world evidence category

- PMLiVE

Novartis’ Bexsero triumphs at UK Prix Galien

The Awards also saw Janssen's Sirturo pick up the Orphan Drug prize

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links